Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
25.60%
↓ 27% below average
Average (9y)
34.89%
Historical baseline
Range
High:64.36%
Low:-7.58%
CAGR
-1.3%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 25.60% |
| 2023 | 58.38% |
| 2022 | 40.16% |
| 2021 | 49.36% |
| 2020 | 30.06% |
| 2019 | 64.36% |
| 2018 | -7.58% |
| 2017 | 28.97% |
| 2016 | 30.86% |
| 2015 | 28.76% |